119 related articles for article (PubMed ID: 6154967)
1. Urinary acid metabolites of biogenic amines in schizophrenic patients.
Domino EF
Schizophr Bull; 1980; 6(2):238-44. PubMed ID: 6154967
[TBL] [Abstract][Full Text] [Related]
2. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
[TBL] [Abstract][Full Text] [Related]
3. The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa.
Davis BA; Kennedy SH; Durden DA; D'Souza J; Goldbloom DS; Boulton AA
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):747-63. PubMed ID: 7504824
[TBL] [Abstract][Full Text] [Related]
4. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
[TBL] [Abstract][Full Text] [Related]
5. Excretion of biogenic amine metabolites in anorexia nervosa.
Riederer P; Toifl K; Kruzik P
Clin Chim Acta; 1982 Aug; 123(1-2):27-32. PubMed ID: 6180848
[TBL] [Abstract][Full Text] [Related]
6. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
[TBL] [Abstract][Full Text] [Related]
7. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.
Demisch L; von der Mühlen H; Bochnik HJ; Seiler N
Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205
[TBL] [Abstract][Full Text] [Related]
8. MAO activity, csf amine metabolites, and drug-free improvement in schizophrenia.
Van Kammen DP; Marder SR; Murphy DL; Bunney WE
Am J Psychiatry; 1978 May; 135(5):567-9. PubMed ID: 645949
[TBL] [Abstract][Full Text] [Related]
9. Interference by endogenous amines in the determination of monoamine oxidase activity of human platelet samples.
Narasimhachari N
Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):143-51. PubMed ID: 451349
[TBL] [Abstract][Full Text] [Related]
10. Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
Herkert EE; Keup W
Psychopharmacologia; 1969; 15(1):48-59. PubMed ID: 5367444
[No Abstract] [Full Text] [Related]
11. Effect of metastatic cancer on platelet monoamine oxidase activity and serotonin metabolism.
Feldman JM
Cancer; 1979 Nov; 44(5):1751-6. PubMed ID: 498046
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.
Wiesel FA; Raaflaub J; Kettler R
Eur J Clin Pharmacol; 1985; 28(1):89-95. PubMed ID: 3987791
[TBL] [Abstract][Full Text] [Related]
13. Platelet monoamine oxidase in chronic schizophrenic patients.
Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral contraceptives on platelet monoamine oxidase, monoamine excretion, and adrenocortical function.
Feldman JM; Roche J
Clin Pharmacol Ther; 1976 Dec; 20(6):670-5. PubMed ID: 991538
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of CSF monoamine metabolites.
Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
[No Abstract] [Full Text] [Related]
16. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
Sullivan J; Stanfield CN; Dackis C
Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
[TBL] [Abstract][Full Text] [Related]
17. Platelet monoamine oxidase activity in acute schizophrenia.
Carpenter WT; Murphy DL; Wyatt RJ
Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia and platelet monoamine oxidase: research strategies.
Buchsbaum MS; Coursey RD; Murphy DL
Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
[TBL] [Abstract][Full Text] [Related]
19. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F
Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
[TBL] [Abstract][Full Text] [Related]
20. Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.
Meltzer HY; Zureick JL
Psychiatry Res; 1987 Oct; 22(2):99-109. PubMed ID: 3685225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
